Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Gritstone oncology
View:
Post by palinc2000 on Feb 01, 2021 6:49am

Gritstone oncology

This news release this am is very interesting on many fronts for HIV treatments but I also draw your attention to the terms of the transaction paragraph.Gritstone up 50 %


https://ir.gritstoneoncology.com/node/7586/pdf

Comment by palinc2000 on Feb 01, 2021 7:03am
Another example of high market valuation of a bio with no revenues 
Comment by Bucknelly21 on Feb 01, 2021 9:05am
Went from 2.20 to 23 very quickly... lol we can't even stay above water for more that a couple days
Comment by palinc2000 on Feb 01, 2021 9:19am
Their pipeline is either in early stage phase 1-2 or pre clinical,,,
Comment by Bucknelly21 on Feb 01, 2021 9:49am
Well it sound like the key for Thtx as far as oncology goes would be good ph1 intern data
Comment by Wino115 on Feb 01, 2021 10:24am
The Gritstone development is sort of the classes research Biotech kind of deal.  They come up with the science, sell it off, and keep a residual.  They're essentially given a massive chunk of future revenues for the investment now.  Can make a lot of sense, but don't think THTX was thinking in those terms.  Nonetheless, can't argue with the shareholder rewards they& ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse